The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm.  Carrying out operations that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere. 

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because

• There is only limited or no evidence of its effectiveness (whether it works or not).
• It is considered a low priority for funding, (for example, cosmetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those procedures that are not funded or where funding will only be made available if specific criteria are met.  Work is also taking place across Greater Manchester to review the EUR policies contained within this list, as well as to develop new policies.  This work will help to ensure that people across the whole of Greater Manchester are able to access these treatments in a fair and equitable manner.

It is important to remember that, while the NHS does not want to carry out operations which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a doctor, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the EUR process, where it will be decided if the NHS will carry out the operation.  The EUR process will make decisions on an individual case by case basis.  The EUR process for requesting funding on an individual patient basis is detailed in the Greater Manchester EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups in Greater Manchester.   The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

General Practitioner (GP) - If you would like to discuss making an individual funding request (IFR), you should contact your General Practitioner, who may do this on your behalf.

Effective Use of Resources (EUR) Team for Greater Manchester

EUR process or funding applications: Tel: 0161 212 6250 / Email: [email protected]

Patient Advice & Liaison Service (PALS) - Tel: 0161 212 6270 / Email: [email protected]

Policies

Bolton CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list)

PbR Excluded Drugs List

PbR Excluded Devices List

Greater Manchester EUR Operational Policy

Bolton CCG Individual Funding Request Panel – Terms of Reference

Bolton CCG Process Review Panel – Terms of Reference

Seeking Medical Treatment Abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.

NHS England Manual (Contains NHS England’s 143 Prescribed Specialised Services)

NHS England Drugs List

NHS England’s Specialised Services Key Documents

NHS England’s Specialised Services IFR Processing System for the North of England

The NHS belongs to us all. It is there to improve our health and well being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

• PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.
• GM Effective Use of Resources (EUR) Team:
  EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]
  EUR policy development: Tel: 0161 212 6212 / Email: [email protected]
• Patient Advice & Liaison Service (PALS)
  Tel: 0161 212 6270 / Email: [email protected]

Policies

• Bury CCG (North East Sector) EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Bury CCG Individual Funding Request Panel – Terms of Reference
• Bury CCG Process Review Panel – Terms of Reference

Seeking medical treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.

NHS England Manual for Prescribed Specialist Services 2017/18

NHS England Drugs List

NHS England’s Specialised Services Key Documents

NHS England’s Specialised Services IFR Processing System for the North of England

The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]

EUR policy development: Tel: 0161 212 6212 / Email: [email protected]

Patient Advice & Liaison Service (PALS): Tel: 0161 212 6270 / Email: [email protected]

Policies

• Manchester CCG EUR Treatment Policies 
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Manchester CCGs Individual Funding Request Panel and Process Review Panel – Terms of Reference

Seeking medical treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere/

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment policies below list those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.

The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below. This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM. The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your care.

GM Effective Use of Resources (EUR) Team:

• EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]
• EUR policy development: Tel: 0161 212 6212 / Email: [email protected]

Patient Advice and Liaison Service (PALS): Tel: 0161 212 6270 / Email: [email protected]

Policies

• Oldham CCG (North East Sector) EUR Treatment Policies(includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Oldham CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference

Treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe. Further information regarding accessing medical treatment in Europe can be found on the NHS website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all. It is there to improve our health and well-being, support us to keep mentally and physically well, to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies.  This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. The GM EUR process will make decisions on an individual case by case basis.  The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.   The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

Please note: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]

EUR policy development: Tel: 0161 212 6212 / Email: [email protected] 

Patient Advice & Liaison Service (PALS): Tel: 0161 212 6270 / Email: [email protected]

Policies

• HMR CCG (North East Sector) EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy

HMR CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference

Seeking medical treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS. Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm. Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere. 

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (whether it works or not)
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care)

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.  The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies.  This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure. 

The GM EUR process will make decisions on an individual case by case basis. The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.  The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]

EUR policy development: Tel: 0161 212 6212 / Email: [email protected]

Patient Advice and Liaison Service (PALS): Tel: 0161 212 4960  / Email: [email protected] Or you can write to:

Patient Advice and Liaison Service
NHS Salford Clinical Commissioning Group

7th Floor
St James’ House
Salford
M6 5FW

Policies

• Salford CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Salford Greater Manchester EUR Operational Policy
• CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference

Seeking Medical Treatment Abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition. Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm.  Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.  The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies.  This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.

The GM EUR process will make decisions on an individual case by case basis.  The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.   The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

• EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]
• EUR policy development: Tel: 0161 212 6212 / Email: [email protected]

Policies

• Stockport CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Stockport CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference

Seeking Medical Treatment Abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives. To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm.  Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or proceduce should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.  The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies.  This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.  The GM EUR process will make decisions on an individual case by case basis.  The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.   The Terms of Reference for our Individual Funding Request Panel can also be found below. PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

Contacts

PLEASE NOTE:The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

• EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]
• EUR policy development: Tel: 0161 212 6212 / Email: [email protected]
• Customer Care Team: Tel: 0161 342 5608 / Email: [email protected]

Policies

NHS Tameside and Glossop CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)

PbR Excluded Drugs List

PbR Excluded Devices List

Greater Manchester EUR Operational Policy

Tameside & Glossop CCG Individual Funding Request Panel – Terms of Reference

Tameside & Glossop CCG Process Review Panel – Terms of Reference

Seeking medical treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.  

The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm.  Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere.

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not)
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met. The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies. This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments / procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.  The GM EUR process will make decisions on an individual case by case basis.  The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.   The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

Please Note: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

• EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]
• EUR policy development: Tel: 0161 212 6212 / Email: [email protected]
• Patient Advice & Liaison Service (PALS): Tel: 0161 873 9577 / Email: [email protected]

Policies

• Trafford CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. Note: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems).
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Trafford CCG Individual Funding Request Panel and Process Review Panel – Terms of Reference

Seeking medical treatment abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.

The NHS belongs to us all.  It is there to improve our health and well-being, support us to keep mentally and physically well,  to get better when we are ill and, when we cannot fully recover to stay as well as we can to the end of our lives.

To make sure that we can provide the best care for the maximum number of people it is vital that we make every penny count.

This means funding treatments that have been demonstrated to work and where there is a high likelihood of benefit and a low likelihood of harm.  Carrying out treatments/procedures that are not of great health benefit uses up resources that could be spent on really making a difference elsewhere. 

As happens in other parts of the country, we may decide that a treatment or procedure should not be routinely funded because:

• There is only limited or no evidence of its effectiveness (i.e. whether it works or not).
• It is considered a low priority for funding, (for example, aesthetic surgery) compared to other treatments (for example, dementia or stroke care).

The Effective Use of Resources (EUR) Treatment Policies below lists those treatments/procedures that are not funded or where funding will only be made available if specific criteria are met.  The Greater Manchester (GM) EUR Steering Group regularly reviews all GM EUR policies and has a programme of work to develop new GM EUR policies.  This work helps to ensure that people across the whole of GM are able to access these treatments in a fair and equitable manner.

It is important to remember that while the NHS does not want to carry out treatments/procedures which have little health benefit in general, there may be overwhelming health benefits for an individual patient. In these cases, a clinician, on behalf of a patient, will explain the exceptional circumstances and request that these are considered through the GM EUR process, where it will be decided if the NHS will carry out the treatment/procedure.  The GM EUR process will make decisions on an individual case by case basis.  The GM EUR process for requesting funding on an individual patient basis is detailed in the GM EUR Operational Policy below.  This process is applied consistently by all Clinical Commissioning Groups (CCGs) in GM.   The Terms of Reference for our Individual Funding Request Panel can also be found below.

Contacts

PLEASE NOTE: The initial decision to make a request for funding will be taken in conjunction with the clinician looking after your condition.

GM Effective Use of Resources (EUR) Team:

EUR process or funding requests: Tel: 0161 212 6250 / Email: [email protected]

EUR policy development: Tel: 0161 212 6212 / Email: [email protected]

Policies

• Wigan Borough CCG EUR Treatment Policies (includes criteria / funding mechanisms / funding request forms – for specific GM policy funding request forms please see end column in list. NOTE: GPs can find GM policies, local treatment policies, summary documents and funding request forms on their clinical systems)
• PbR Excluded Drugs List
• PbR Excluded Devices List
• Greater Manchester EUR Operational Policy
• Wigan CCG Individual Funding Request Panel – Terms of Reference
• Wigan CCG Process Review Panel – Terms of Reference

Treatments which are not the funding responsibility of CCGs in England

There are a number of treatments and conditions which are funded directly by NHS England, which means that CCGs in England are not responsible for funding the care for patients related to that particular treatment or condition.  Further information regarding the treatments and conditions funded by NHS England can be found on their website.

Seeking Medical Treatment Abroad

As an NHS patient, you have the right to receive treatment anywhere in the European Economic Area (EEA), provided that the treatment is funded by the NHS.  Our EUR policies above also apply to treatment accessed in Europe.   Further information regarding accessing medical treatment in Europe can be found on the NHS Choices website.